UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 31, 2005
Chiron Corporation
(Exact name of registrant as specified in its charter)
Delaware |
|
0-12798 |
|
94-2754624 |
(State or other |
|
(Commission |
|
(IRS Employer |
jurisdiction of |
|
File Number) |
|
Identification No.) |
incorporation) |
|
|
|
|
4560 Horton Street, Emeryville, CA |
|
94608 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code (510) 655-8730
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
ý Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On October 31, 2005, Chiron Corporation announced that it entered into a definitive agreement with Novartis AG and Novartis Corporation.
The press release dated October 31, 2005 is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) |
Exhibits. |
|
|
|
|
|
|
|
Exhibit Number |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release issued October 31, 2005. |
# # #
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CHIRON CORPORATION |
||
|
(Registrant) |
||
|
|
|
|
|
|
|
|
Date: October 31, 2005 |
By: |
/s/ Jessica Hoover |
|
|
|
Jessica Hoover |
|
|
|
Vice President, Head of Corporate |
|
|
|
Business Development |
3